- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04198194
Apple Heart & Movement Study
July 19, 2021 updated by: Calum A. MacRae, Apple Inc.
This study will look for factors that affect heart health and potentially cause deterioration in mobility or heart function.
Participant's Apple Watch and iPhone can help researchers gain a better understanding of potential early warning signs.
This can lead to new interventions and products that will help millions lead longer, healthier, and more active lives.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
500000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Research Studies Support Center
- Phone Number: 833-237-3881
- Email: AppleHeartandMovementStudy@bwh.harvard.edu
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Recruiting
- Brigham and Women's Hospital
-
Contact:
- Calum MacRae, MD, PhD
- Phone Number: 617-525-9914
- Email: cmacrae@bwh.harvard.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Participants will self-enroll in this trial, if they meet inclusion criteria, and there will be no active recruitment of any particular population.
Invitation to volunteer.
Description
Inclusion Criteria:
- Be at least 18 years old (at least 19 years old in Alabama and Nebraska, at least 21 years old in Puerto Rico);
- Live in the United States of America;
- Have an iPhone;
- Have an Apple Watch (Series 1 or later) at the time of enrollment;
- Have the Apple Research app installed on your iPhone;
- Be comfortable communicating in written and spoken English;
- Not share your iCloud account, iPhone, or Apple Watch with anyone else;
- Be willing and able to provide informed consent to participate in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Participants with events
Individuals who have experienced any of the listed outcomes
|
Apple Heart & Movement Study in Apple Research app
|
Participants without events
Individuals who have not experienced any of the listed outcomes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants with Chronic Disease Events
Time Frame: quarterly (every 90 days) through study completion (up to 5 years)
|
Change in number of participants with incident cardiovascular disease events (including myocardial infarction, coronary revascularization, heart failure hospitalization, stroke/TIA hospitalization, atrial fibrillation, and atrial fibrillation hospitalization), fall events, and other hospitalizations, assessed by patient report.
|
quarterly (every 90 days) through study completion (up to 5 years)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Calum MacRae, MD, PhD, cmacrae@bwh.harvard.edu
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 14, 2019
Primary Completion (ANTICIPATED)
November 14, 2024
Study Completion (ANTICIPATED)
November 14, 2024
Study Registration Dates
First Submitted
November 13, 2019
First Submitted That Met QC Criteria
December 12, 2019
First Posted (ACTUAL)
December 13, 2019
Study Record Updates
Last Update Posted (ACTUAL)
July 23, 2021
Last Update Submitted That Met QC Criteria
July 19, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- 2019P002257
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prevention
-
Children's Hospital of PhiladelphiaUniversity of Pennsylvania; National Institute of Nursing Research (NINR); Pennsylvania...CompletedPrevention Harmful Effects | Accidents, Traffic | Accident PreventionUnited States
-
Prof Mags BeksinskaCompletedHIV Prevention | Pregnancy PreventionSouth Africa
-
Yale UniversityCompletedHIV Prevention | STI PreventionUnited States
-
Centers for Disease Control and PreventionUniversity of Minnesota; The Fenway Institute; AIDS Action Committee of Massachusetts and other collaboratorsCompletedHIV Prevention | STD PreventionUnited States
-
Children's Hospital Medical Center, CincinnatiCompletedPreventionUnited States
-
Brown UniversityUniversity of California, Los Angeles; National Institute of Nursing Research... and other collaboratorsRecruiting
-
Brown UniversityThe Miriam HospitalCompletedOptimizing PrEP Uptake & Adherence Among Male Sex Workers (MSW) Using a 2-stage Randomization DesignPreventionUnited States
-
King Abdulaziz UniversityUnknown
-
Carnegie Mellon UniversityUniversity of Pennsylvania; Yale UniversityCompletedPreventionUnited States
Clinical Trials on Predictors of events
-
Mansoura UniversityUnknownAnastomotic LeakEgypt
-
Hospital Galdakao-UsansoloHospital Donostia; Hospital de Basurto; Hospital del Mar; Instituto de Salud Carlos... and other collaboratorsCompleted
-
Fudan UniversityCompletedPancreatic Ductal AdenocarcinomaChina
-
Hospital Galdakao-UsansoloHospital Donostia; Hospital de Basurto; Hospital Universitario de Canarias; Hospital... and other collaboratorsCompleted
-
Sun Yat-sen UniversityUnknownNasopharyngeal NeoplasmsChina
-
German University of Health and SportsRecruiting
-
Tianjin Medical University General HospitalUnknownCardiovascular Disease | AtherosclerosisChina
-
University of ZurichCompletedAdverse Drug ReactionsSwitzerland
-
University Hospital, MontpellierCompleted
-
University of Erlangen-Nürnberg Medical SchoolActive, not recruitingHypertension | Genetic Predisposition | Renal DenervationGermany, United Kingdom